Fluconazole (all routes except local only) - Cumulative dose ≤ 150 mg updated on 01-29-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.03 [0.89, 1.19]0%3 studies44,7845,229not evaluable ROB-
Limb defects0.84 [0.54, 1.30]31%3 studies12,4435,229not evaluable ROB-
Congenital heart defects1.29 [0.96, 1.74]0%2 studies7,8854,316not evaluable ROB-
Major congenital malformations1.03 [0.89, 1.19]0%3 studies44,7845,229not evaluable ROB-
Polydactyly0.71 [0.16, 3.07]0%2 studies5994,316not evaluable ROB-
Tetralogy of Fallot3.18 [1.18, 8.56]-1 study2914,082not evaluable ROB5.81 [1.64; .]
16 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions1.09 [0.23, 5.14]90%2 studies29,4961,759not evaluable ROB-
Ectopic pregnancy--0 study-
2 non statistically significant endpoints reported in only one study